Novel protein biomarkers for risk stratification and personalized medicine

Urinary clusterin and uEGF are mechanism-informed pharmacodynamic biomarkers reflecting distinct intrarenal pathways engaged by ERA and SGLT2i therapy, respectively. These biomarkers complement albuminuria by capturing tubular injury and repair, providing a more comprehensive biological assessment of treatment effects and heterogeneity in CKD.

Publication Details

Journal: Nephrology Dialysis Transplantation
Published: 2026-03-20
DOI: https://doi.org/10.1093/ndt/gfag068
Primary Topic: Clusterin in disease pathology
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel protein biomarkers for risk stratification and personalized medicine

Mar 20, 2026

Nephrology Dialysis Transplantation

Clusterin in disease pathology

article

Novel protein biomarkers for risk stratification and personalized medicine

March 20, 2026article en

Abstract

Nephrology Dialysis Transplantation

Good health and well-being

Openalex Percentile: Top 10%

Clusterin in disease pathology

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel protein biomarkers for risk stratification and personalized medicine · Nephrology Dialysis Transplantation (2026) | TGRS Research Map | TGRS